These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14576518)

  • 1. Non-invasive functional and biochemical assessment of mitoxantrone cardiotoxicity in patients with multiple sclerosis.
    Spindler M; Weilbach F; Beer M; Sandstede J; Köstler H; Strotmann J; Voelker W; Hahn D; Ertl G; Gold R
    J Cardiovasc Pharmacol; 2003 Nov; 42(5):680-7. PubMed ID: 14576518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
    Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
    Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis: a tissue Doppler echocardiographic analysis.
    Pattoneri P; Sozzi F; Pelà G; Montanari E; Moruzzi P; Borghetti A; Cappellini MD
    Echocardiography; 2009 Apr; 26(4):397-402. PubMed ID: 19017314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
    Joyce E; Mulroy E; Scott J; Melling J; Goggin C; McGorrian C; O'Rourke K; Lynch T; Mahon N
    J Card Fail; 2013 Aug; 19(8):571-6. PubMed ID: 23910587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosis.
    De Castro S; Cartoni D; Millefiorini E; Funaro S; Gasperini C; Morino S; Tallarico D; Beni S
    J Clin Pharmacol; 1995 Jun; 35(6):627-32. PubMed ID: 7665724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac effects of mitoxanthrone therapy in patients with multiple sclerosis.
    Pastuszak Ż; Tomczykiewicz K; Piusińska-Macoch R; Stępień A
    Kardiol Pol; 2016; 74(4):380-4. PubMed ID: 26412472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis.
    Zingler VC; Nabauer M; Jahn K; Gross A; Hohlfeld R; Brandt T; Strupp M
    Eur Neurol; 2005; 54(1):28-33. PubMed ID: 16088176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients--preliminary study.
    Luchowski P; Mitosek-Szewczyk K; Bartosik-Psujek H; Rubaj A; Jankiewicz M; Wojczal J; Szczepańska-Szerej A; Stelmasiak Z
    Clin Neurol Neurosurg; 2009 Oct; 111(8):676-8. PubMed ID: 19632767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac time intervals by tissue Doppler imaging M-mode echocardiography: reproducibility, reference values, association with clinical characteristics and prognostic implications.
    Biering-Sørensen T
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
    Hamzehloo A; Etemadifar M
    Arch Iran Med; 2006 Apr; 9(2):111-4. PubMed ID: 16649351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane.
    Bernitsas E; Wei W; Mikol DD
    Ann Neurol; 2006 Jan; 59(1):206-9. PubMed ID: 16374818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of pediatric patients treated with mitoxantrone for multiple sclerosis.
    Kornek B; Bernert G; Rostasy K; Mlczoch E; Feucht M; Prayer D; Vass K; Seidl R
    Neuropediatrics; 2011 Feb; 42(1):7-12. PubMed ID: 21557144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.
    Shaikh AY; Suryadevara S; Tripathi A; Ahmed M; Kane JL; Escobar J; Cerny J; Nath R; McManus DD; Shih J; McGuiness ME; Tighe DA; Meyer TE; Ramanathan M; Aurigemma GP
    Echocardiography; 2016 Aug; 33(8):1166-77. PubMed ID: 27109429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of myocardial performance index in multiple sclerosis mitoxantrone-induced cardiotoxicity.
    Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Montanari A
    Heart Asia; 2012; 4(1):91-4. PubMed ID: 27326038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
    Goffette S; van Pesch V; Vanoverschelde JL; Morandini E; Sindic CJ
    J Neurol; 2005 Oct; 252(10):1217-22. PubMed ID: 15834643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.